Autoantibody to 43 kDa Protein in Inclusion Body Myositis
Author Information
Author(s): Salajegheh Mohammad, Lam Theresa, Greenberg Steven A.
Primary Institution: Brigham and Women's Hospital
Hypothesis
We sought to identify novel autoantibodies with high specificity for inclusion body myositis (IBM).
Conclusion
Circulating antibodies against a 43-kDa muscle autoantigen may lead to the discovery of a novel biomarker for IBM.
Supporting Evidence
- 52% of IBM patient samples recognized a 43 kDa muscle protein.
- No other autoimmune disease or healthy volunteer samples recognized this protein.
- The detection of the 43 kDa muscle autoantigen had a sensitivity of 52% and specificity of 100% for IBM.
Takeaway
This study found that some people with a muscle disease called inclusion body myositis have special antibodies that could help doctors identify the disease better.
Methodology
Plasma autoantibodies from 65 people, including 25 with IBM, were analyzed by immunoblots against normal human muscle.
Limitations
The study's sample size was limited to 65 individuals, which may affect the generalizability of the findings.
Participant Demographics
Patients with IBM had a mean age of 68 years, while those with other autoimmune myopathies had a mean age of 48 years.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website